Timothy McInerney
CIK: 0001226020
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SLN
Silence Therapeutics plc
Director
Discretionary Trading P&L
Holdings
About MCINERNEY TIMOTHY
MCINERNEY TIMOTHY (SEC CIK 0001226020) files insider reports with the SEC as Director of Silence Therapeutics plc (SLN).
Signal8 holds 3 ownership filings by MCINERNEY TIMOTHY (1 Form 3, 2 Form 4), filed between May 20, 2025 and Jan 6, 2026. Those filings report 2 transactions, from May 5, 2025 to Jan 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on MCINERNEY TIMOTHY's filings is in LONDON, X0.
Recent filings by MCINERNEY TIMOTHY
Other insiders filing for Silence Therapeutics plc (SLN)
- Griffiths Richard Ian, 10% Owner
- Ede-Golightly James, Director
- Romano Steven J., EVP and Chief R&D Officer
- HELLUMS RHONDA LYNETTE, Chief Financial Officer
- Lemus David, Director
- Ross Iain, Director